Russia to Miss Covid-19 Vaccine Goal Amid Production Hurdles
- Target of 30 million doses this year ‘nonsense,’ minister says
- Russia was first country to register a vaccine for use
This article is for subscribers only.
Russia is going to miss its target of making 30 million doses of an experimental Covid-19 vaccine this year due to setbacks maintaining the serum’s stability while expanding production.
“The main task is to scale up production,” Industry Minister Denis Manturov said in an interview with Bloomberg TV. “To have 30 million doses by year-end is impossible, it is nonsense.”